Le Lézard

News by subject: Annual Meeting

1 2 3 4 5 6 7 8 9 10 11

7 june 2024

16:30
Wallbox , a leading provider of electric vehicle (EV) charging solutions, today announced the addition of three new members to its Board of Directors at its 2024 Annual General Meeting of Shareholders. The three new Directors voted in by...

09:15
ImmunityBio, Inc. announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time. The Annual Meeting will be held in a virtual-only format and there will not be a physical location for...

07:20
Natuzzi S.p.A. ("Natuzzi" or the "Company" and, together with its subsidiaries, the "Natuzzi Group") announced today that it held on first call its annual general shareholders' meeting on May 30, 2024 (the "Annual General Meeting"). At the Annual...


6 june 2024

16:35
WisdomTree, Inc. , a global financial innovator, today announced that Egan-Jones Ratings Co. ("Egan-Jones"), an independent proxy advisory firm, has recommended that stockholders vote "FOR" all Company-recommended proposals, including all nine...

16:20
Universal Display Corporation (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, will hold its 2024 Annual Meeting of Shareholders in a virtual-only format beginning at 10:00 A.M. Eastern Time...

16:10
Granite Real Estate Investment Trust ("Granite REIT") and Granite REIT Inc. ("Granite GP") (collectively, "Granite") announced today the results of the matters voted on at their joint annual general and special meetings of stapled unitholders held...

14:45
Sierra Metals Inc. ("Sierra Metals" or the "Company") is pleased to announce that it has filed its management information circular (the "Circular") in connection with the Company's upcoming annual meeting of shareholders (the "Meeting"). The...

12:40
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, is pleased to announce that at the General Meeting of the Company held at 11:00 a.m....

08:30
BT Brands, Inc. , a growing multi-concept restaurant operator, today announced that its board of directors has approved the repurchase of up to 625,000 shares, representing approximately 10% of its outstanding common shares. The share purchases may...

07:30
Crescita Therapeutics Inc. ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its Annual General and Special Meeting of Shareholders held at its...


5 june 2024

18:05
Afya Limited ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that the resolution set out in its Notice of Annual General Meeting dated May 17, 2024 was duly passed at...

16:50
Walmart Inc. today announced shareholder voting results for its Annual Shareholders' Meeting, which was conducted virtually. Approximately 91% of all outstanding shares were represented at the meeting. Greg Penner, Chairman, expressed his...

08:05
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, recently presented a poster on NTX-472, its new preclinical drug candidate for B cell lymphoma,...

06:50
US Foods Holding Corp. , one of the largest foodservice distributors in the United States, will host its 2024 Investor Day at its Rosemont, Ill. headquarters today beginning at 9:00 a.m. Central Time. The event will include formal presentations and...


4 june 2024

09:10
Omeros Corporation today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Thursday, June 6, 2024, starting at 10:00 a.m. Pacific Time. A live webcast of the Annual Meeting...


3 june 2024

18:35
Aurinia Pharmaceuticals Inc. (Aurinia or the Company) filed a supplement (the "Supplement") to the Company's Management Information and Proxy Statement dated June 3, 2024 (the "Proxy Statement/Circular") for its Annual General Meeting of...

16:35
Ferguson Enterprises Inc. (the "Company") today announces that it will hold its first annual meeting of stockholders (the "Annual Meeting") on December 5, 2024 as the successor registrant of Ferguson plc, subject to the consummation of the Merger (as...

14:35
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor receptor-mutated (EGFR-mutated) non-small cell lung cancer...

14:20
To address a gap in knowledge surrounding clinical trial participation impacts on unplanned healthcare utilization and hospice enrollment in adults with cancer, investigators from The US Oncology Network (The Network), the largest organization of its...

13:45
Zones, a global solution provider renowned for its comprehensive IT services and solutions, is thrilled to announce that it has been awarded the prestigious 2023 Class IV Supplier of the Year Award by the Mountain Plains Minority Supplier Development...

09:10
Merck KGaA, Darmstadt, Germany, a leading science and technology company that operates its Healthcare business as EMD Serono in the US and Canada, today shared updates on the company's oncology pipeline and focused approach to the research and...

08:10
ASCO Annual Meeting ? Massive Bio, renowned leader in AI-driven oncology solutions, and Un Ensayo Para Mi (UEPM), a premier clinical trial search platform in Latin America, are excited to announce an expanded partnership. This collaboration will...

07:10
Calidi Biotherapeutics Inc. ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the presentation of three abstracts in a poster session during the 2024 American Society of...

07:05
TriSalus Life Sciences, Inc. , an oncology company integrating its novel Pressure Enabled Drug Deliverytm (PEDDtm) technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced that data from its...


2 june 2024

17:35
Genmab A/S today announced new efficacy and safety data from two ongoing Phase 1/2 clinical trials evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, in adult patients with certain types of follicular lymphoma...

11:00
GSK plc (LSE/NYSE: GSK) today announced positive results from an interim analysis of the DREAMM-8 phase III head-to-head trial evaluating belantamab mafodotin, in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care,...

08:10
Positive results from the ADRIATIC Phase III trial showed AstraZeneca's IMFINZI® (durvalumab) ?demonstrated statistically significant and clinically meaningful improvements in the dual primary endpoints of overall survival (OS) and progression-free...


1 june 2024

08:05
Gilead Sciences, Inc. and Arcus Biosciences, Inc. today announced longer-term efficacy and safety results from Arm A1 of the Phase 2 EDGE-Gastric study. These updated data show consistent objective response rate (ORR) and provide mature...

08:05
ASCO Annual Meeting ? Massive Bio, pioneering leader in AI-driven oncology solutions, is excited to announce the launch of its latest product, Drug Utilization Optimizer (DUO), at the upcoming ASCO Annual Meeting 2024. The innovative analytics and...


31 may 2024

17:10
Boston Omaha Corporation (the "Company") announced today that the date of its 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting") will be September 20, 2024. The meeting will be held at The Salvation Army Omaha Kroc Center ? Joyce Mammel...

12:50
WisdomTree, Inc. , a global financial innovator, today announced that Glass Lewis, a leading independent proxy advisory firm, has recommended that stockholders vote "FOR" all WisdomTree proposals, including "FOR" all nine members of WisdomTree's...

09:05
Artera, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, will present three abstracts at the 2024 ASCO Annual Meeting demonstrating that its multimodal artificial intelligence (MMAI) platform provides...

08:10
Masimo announced today that its Board of Directors has nominated Christopher Chavez for election as a Class II Director at the Company's 2024 Annual Meeting of Stockholders. Following Rolf Classon's unexpected resignation from the Board on May 10,...

08:05
Quantum-Si Incorporated ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Companytm, today announced presentations at two upcoming industry conferences. Gloria Sheynkman, PhD, Assistant Professor in the Department of Molecular...

07:05
FiscalNote Holdings, Inc. ("FiscalNote"), a leading AI-driven enterprise SaaS technology provider of global policy and market intelligence, today announced it has convened and concluded its 2024 Annual Meeting of Shareholders (the "Annual Meeting")...


30 may 2024

16:35
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it will present new data related to its DecisionDx-Melanoma and DecisionDx-UM tests at the 2024 American Society of Clinical...

16:05
Softchoice Corporation ("Softchoice" or the "Company") announced today the results of its annual general and special meeting of shareholders (the "AGM") held on Thursday, May 30, 2024. 1. Election of Directors At the AGM, Softchoice shareholders...

07:35
Strand Therapeutics, the world's first programmable mRNA company developing curative therapies for cancer, autoimmune diseases, and beyond, today announced the first patient has been dosed in their Phase 1, first-in-human trial of STX-001, an...

01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...


29 may 2024

17:25
NovaBay® Pharmaceuticals, Inc. the "Company") announces that a quorum was reached and that all proposals in the Company's Definitive Proxy Statement filed on April 18, 2024 with the Securities and Exchange Commission (the "SEC") were approved by...

17:05
CarMax, Inc. will report its financial results for the first quarter ended May 31, 2024 before the market opens on June 21, 2024, and it will host a conference call with investors at 9:00 a.m. ET to discuss these results. Participants on the call...

17:05
Aventine Property Group, Inc. ("Aventine" or the "Company"), one of the largest internally managed REITs serving the legal adult- and medical-use cannabis industry, announced today that it has postponed the date of its 2024 Annual Meeting of...

16:35
Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2024 annual meeting of...

16:35
Customers Bancorp (the "Company"), parent company of Customers Bank (the "Bank"), held its annual shareholder meeting today and shareholders approved all proposals put to a vote. Robert J. Buford, Rajeev V. Date and Jay S. Sidhu were reelected as...

16:10
SilverBow Resources, Inc. ("SilverBow" or the "Company") today announced that SilverBow shareholders have voted to re-elect all three of the Company's director nominees ? Gabriel L. Ellisor, Kathleen McAllister and Charles W. Wampler, based on the...

12:35
Chevron Corporation today provided an overview of the company's business performance and plans at its 2024 Annual Meeting of Stockholders. "Chevron continues to deliver strong operational performance, maintain cost and capital discipline and...

11:25
Biomedical engineers, clinicians, technicians, researchers and educators from across the world will gather in Orlando, Fla., to showcase and discuss the latest advancements in artificial intelligence, data science, neuroengineering, and more during...

09:15
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, will present updates on three ongoing clinical trials in poster presentations during the 2024 American...

08:15
Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced new data to be presented at The American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from May 31 ? June 2, 2024. These...

06:10
Following its Annual General Meeting ("AGM") held at 9:00am (Mountain Daylight Time) on Tuesday 28 May 2024, AngloGold Ashanti plc (the "Company" or "AngloGold Ashanti") announces the results of the poll vote for each resolution set out in the notice...

1 2 3 4 5 6 7 8 9 10 11